Managing Depression: Can Sertraline on sleep architecture Make a Real Difference? (What New Research Reveals)
However, the generalizability of these findings is limited because of a number of reasons.
Long-term human survival cohorts and Phase 3 prevention trials covering UKPDS 34 / TAME Metformin AMPK longevity pathways, muscle protein synthesis across eight decades of life, and adult vaccine coadministration trials. Explore 817 indexed studies and multi-trial syntheses with verified PubMed PMIDs, participant sample sizes (N), and Absolute vs. Relative Risk numbers.
The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).
However, the generalizability of these findings is limited because of a number of reasons.
Statins are effective medicines and confer benefit to patients in terms of primary and secondary prevention of coronary heart disease.
In patients with the metabolic syndrome, rosuvastatin 10 mg improved LDL cholesterol (-47%), non-HDL cholesterol (-43%), non-HDL cholesterol/HDL cholesterol ratio (-47%), apolipoprotein B (-37%), apolipoprotein...
Serum soluble ST2 is a novel biomarker for neurohormonal activation in patients with heart failure.
Combination therapy with metformin and insulin improves blood sugar control and reduces insulin requirements.
Among individuals with MDD, exercise therapy is feasible and is associated with significant therapeutic benefit, especially if exercise is continued over time.
Differences in QT dispersion (a predictor for sudden death) were observed in a subgroup of patients in the ELITE heart failure study of losartan compared with captopril, and may explain improved survival with losartan.
In patients with Doppler evidence of diastolic dysfunction at rest and a hypertensive response to exercise, Ang II receptor blockade blunts the hypertensive response to exercise, increases exercise tolerance and improves...
This cost increase translated into a cost-effectiveness ratio of USD 4,047 per year of life gained for losartan relative to captopril.
Alcohol use and infrequent exercise were inversely associated with risk of BPH surgery; however, risk estimates were not consistent across categories of exercise and alcohol frequency.
In this study Mx 2% applied to the skin solution was non-toxic but was not effective in the prevention of chemotherapy-induced hair loss.
Preliminary animal and in vitro investigations have shown that losartan produces beneficial effects on cardiac function, kidney function, and survival that are similar to those of ACE inhibitors.
All patients are now in full symptom relief averaging 38 months in duration.
The use of a GIC liner after SCR-SD did not improve restoration survival and was not associated with better pulp vitality preservation. Composite restorations using universal adhesive applied in selective enamel etching mode placed directly over the remaining dentin showed favorable restorative and biological outcomes after 30-36 months.
In recently menopausal women, the type of MHT did not significantly influence the association of markers of blood thrombogenicity with development of WMH in the brain.
The study did not show non-inferiority for StrataXRT; overall skin reaction severity and costs were significantly lower under Mepitel film; however, StrataXRT was better tolerated.
This interim analysis demonstrates the feasibility and safety of dosimetry-guided PRRT strategies, including individualized 177 Lu escalation and tandem 90 Y/ 177 Lu.
Adjuvant uracil-tegafur and leucovorin significantly prolonged the recurrence-free survival but not the overall survival.
The 3-year overall survival (OS), locoregional relapse-free survival (LRRFS), distant metastasis-free survival (DMFS) and progression-free survival (PFS) in UTI group and control group are similar between two groups.
Adding paclitaxel to CRT with capecitabine and MMC improves cCR rate and long-term outcomes in SCAC at the cost of higher toxicity.
This subgroup analysis confirmed that EV, with consistent real-world benefits and safety/tolerability in the EV-301 Japanese subgroup and overall study population, represents an important treatment option for previously...
The regular use of extensive peritoneal lavage in patients with locally advanced gastric cancer, regardless of peritoneal cytology, has not been effective as prophylaxis of.
PES incidence was non-inferior between groups.
Total tumor volume is strongly prognostic for early recurrence and OS in patients who underwent complete local treatment of initially unresectable CRLM, both in the CAIRO5 trial and the validation cohort.
An online screening intervention is feasible and likely effective in encouraging members of an Internet weight-loss community to discuss obstructive sleep apnea with their healthcare provider.
Single-drug treatment with enavogliflozin 0.3 mg improved glycaemic control in people with T2DM.
CONCLUSIONS: The immunogenicity of 5-dose and 4-dose schedules of the freeze-dried human rabies vaccine (MRC-5 cells) was non-inferior to that of the human diploid cell vaccine, and the safety was good after vaccination.
MAD proved to be more effective than Topiramate in managing epileptic spasms refractory to first-line treatment.
Methods : Adults with obesity and NAFLD (n = 80) were randomized into one of four groups for 3 months: combination of ADF (600 kcal "fast day," alternated with an ad libitum intake "feast day") and moderate-intensity aerobic...
The results of this study showed that Mucosamin spray was able to significantly improved radiation-induced oral mucositis in patients with oral squamous cell carcinoma.
Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.
Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.
Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.
Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.